3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

被引：283

作者：

Cardoso, F. ^{[1
,2
]}

Costa, A. ^{[3
,4
]}

Senkus, E. ^{[5
]}

Aapro, M. ^{[6
]}

Andre, F. ^{[7
]}

Barrios, C. H. ^{[8
]}

Bergh, J. ^{[9
,10
,11
]}

Bhattacharyya, G. ^{[12
]}

Biganzoli, L. ^{[13
]}

Cardoso, M. J. ^{[2
]}

Carey, L. ^{[14
]}

Corneliussen-James, D. ^{[15
]}

Curigliano, G. ^{[16
]}

Dieras, V. ^{[17
]}

El Saghir, N. ^{[18
]}

Eniu, A. ^{[19
]}

Fallowfield, L. ^{[20
]}

Fenech, D. ^{[21
]}

Francis, P. ^{[22
]}

Gelmon, K. ^{[23
]}

Gennari, A. ^{[24
]}

Harbeck, N. ^{[25
]}

Hudis, C. ^{[26
]}

Kaufman, B. ^{[27
]}

Krop, I. ^{[28
]}

Mayer, M. ^{[29
]}

Meijer, H. ^{[30
]}

Mertz, S. ^{[31
]}

Ohno, S. ^{[32
]}

Pagani, O. ^{[33
,34
]}

Papadopoulos, E. ^{[35
]}

Peccatori, F. ^{[3
,4
]}

Penault-Llorca, F. ^{[36
]}

Piccart, M. J. ^{[37
]}

Pierga, J. Y. ^{[38
]}

Rugo, H. ^{[39
]}

Shockney, L. ^{[40
]}

Sledge, G. ^{[41
]}

Swain, S. ^{[42
]}

Thomssen, C. ^{[43
]}

Tutt, A. ^{[44
,45
]}

Vorobiof, D. ^{[46
]}

Xu, B. ^{[47
,48
]}

Norton, L. ^{[49
]}

Winer, E. ^{[28
]}

机构：

[1] Champalimaud Clin Ctr, European Sch Oncol, Lisbon, Portugal

[2] Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[3] European Sch Oncol, Milan, Italy

[4] European Sch Oncol, Bellinzona, Switzerland

[5] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[6] Genolier Canc Ctr, Breast Ctr, Genolier, Switzerland

[7] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[8] PUCRS Sch Med, Dept Med, Porto Alegre, RS, Brazil

[9] Karolinska Inst, Radiumhemmet, Dept Oncol, Stockholm, Sweden

[10] Canc Ctr Karolinska, Stockholm, Sweden

[11] Karolinska Univ Hosp, Stockholm, Sweden

[12] Fortis Hosp, Dept Med Oncol, Kolkata, India

[13] Hosp Prato, Dept Med Oncol, Prato, Italy

[14] UNC Lineberger Comprehens Canc Ctr, Dept Hematol & Oncol, Chapel Hill, NC USA

[15] METAvivor Res & Support, Annapolis, MD USA

[16] European Inst Oncol, Div Expt Therapeut, Milan, Italy

[17] Inst Curie, Dept Med Oncol, Paris, France

[18] Amer Univ Beirut, Breast Ctr Excellence, NK Basile Canc Inst, Beirut, Lebanon

[19] Canc Inst I Chiricuta, Dept Breast Tumors, Cluj Napoca, Romania

[20] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England

[21] Europa Donna Malta, Breast Care Support Grp, Mtarfa, Malta

[22] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia

[23] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada

[24] Galliera Hosp, Dept Med Oncol, Genoa, Italy

[25] Brustzentrum Univ Munchen, Munich, Germany

[26] Mem Sloan Kettering Canc Ctr, Breast Med Serv, 1275 York Ave, New York, NY 10021 USA

[27] Sheba Med Ctr, Tel Hashomer, Israel

[28] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[29] Adv Breast Canc Org, New York, NY USA

[30] Radvoud Univ, Dept Radiat Oncol, Med Ctr, Nijmegen, Netherlands

[31] Metastat Breast Canc Network US, Inversness, FL USA

[32] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan

[33] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[34] Breast Unit Southern Switzerland, Bellinzona, Switzerland

[35] Europa Donna, Nicosia, Cyprus

[36] Ctr Comprehens Canc, Jean Perrin Ctr, Clermont Ferrand, France

[37] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Brussels, Belgium

[38] Univ Paris 05, Inst Curie, Dept Med Oncol, Paris, France

[39] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Med, Breast Oncol Program, San Francisco, CA USA

[40] Johns Hopkins Breast Ctr, Dept Surg & Oncol, Baltimore, MD USA

[41] Indiana Univ, Med Ctr, Indianapolis, IN USA

[42] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA

[43] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Germany

[44] Kings Coll London, Breakthrough Breast Canc Res Unit, London, England

[45] Guys & St Thomass NHS Fdn Trust, London, England

[46] Sandton Oncol Ctr, Johannesburg, South Africa

[47] Chinese Acad Med Sci, Dept Med Oncol, Beijing, Peoples R China

[48] Peking Union Med Coll, Beijing, Peoples R China

[49] Mem Sloan Kettering Canc Ctr, Breast Canc Program, 1275 York Ave, New York, NY 10021 USA

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷 / 01期

关键词：

PROGRESSION-FREE SURVIVAL; PHASE-III TRIAL; OPEN-LABEL; ESTROGEN-RECEPTOR; TRASTUZUMAB EMTANSINE; 1ST-LINE TREATMENT; ZOLEDRONIC ACID; BONE METASTASES; PERTUZUMAB P; DOUBLE-BLIND;

D O I：

10.1093/annonc/mdw544

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：16 / 33

页数：18

共 68 条

[1] A Practical Approach to Fatigue Management in Colorectal Cancer [J].

Aapro, Matti ;

Scotte, Florian ;

Bouillet, Thierry ;

Currow, David ;

Vigano, Antonio .

CLINICAL COLORECTAL CANCER, 2017, 16 (04) :275-285

[2] Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial [J].

Amadori, Dino ;

Aglietta, Massimo ;

Alessi, Barbara ;

Gianni, Lorenzo ;

Ibrahim, Toni ;

Farina, Gabriella ;

Gaion, Fernando ;

Bertoldo, Francesco ;

Santini, Daniele ;

Rondena, Roberta ;

Bogani, Paola ;

Ripamonti, Carla I. .

LANCET ONCOLOGY, 2013, 14 (07) :663-670

[3] Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer [J].

Amir, Eitan ;

Miller, Naomi ;

Geddie, William ;

Freedman, Orit ;

Kassam, Farrah ;

Simmons, Christine ;

Oldfield, Maria ;

Dranitsaris, George ;

Tomlinson, George ;

Laupacis, Andreas ;

Tannock, Ian F. ;

Clemons, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :587-592

[4] The co-administration of pertuzumab (P) and trastuzumab (T) as a single infusion, followed by vinorelbine (V), in first-line (1L) treatment of HER2-positive locally advanced or metastatic breast cancer (MBC) patients (pts): VELVET study interim analysis. [J].

Andersson, Michael ;

Lopez-Vega, Jose Manuel ;

Petit, Thierry ;

Zamagni, Claudio ;

Donica, Margarita ;

Kamber, Julia ;

Perez, Edith A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[5] Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The HERNATA Study [J].

Andersson, Michael ;

Lidbrink, Elisabeth ;

Bjerre, Karsten ;

Wist, Erik ;

Enevoldsen, Kristin ;

Jensen, Anders B. ;

Karlsson, Per ;

Tange, Ulla B. ;

Sorensen, Peter G. ;

Moller, Susanne ;

Bergh, Jonas ;

Langkjer, Sven T. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :264-271

[6] Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) [J].

Andre, Fabrice ;

Bachelot, Thomas ;

Commo, Frederic ;

Campone, Mario ;

Arnedos, Monica ;

Dieras, Veronique ;

Lacroix-Triki, Magali ;

Lacroix, Ludovic ;

Cohen, Pascale ;

Gentien, David ;

Adelaide, Jose ;

Dalenc, Florence ;

Goncalves, Anthony ;

Levy, Christelle ;

Ferrero, Jean-Marc ;

Bonneterre, Jacques ;

Lefeuvre, Claudia ;

Jimenez, Marta ;

Filleron, Thomas ;

Bonnefoi, Herve .

LANCET ONCOLOGY, 2014, 15 (03) :267-274

[7]

[Anonymous], J CLIN ONCOL S, DOI DOI 10.1200/jco.2014.32.15_suppl.lba9500

[8] Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study [J].

Bachelot, Thomas ;

Bourgier, Celine ;

Cropet, Claire ;

Ray-Coquard, Isabelle ;

Ferrero, Jean-Marc ;

Freyer, Gilles ;

Abadie-Lacourtoisie, Sophie ;

Eymard, Jean-Christophe ;

Debled, Marc ;

Spaeth, Dominique ;

Legouffe, Eric ;

Allouache, Djelila ;

El Kouri, Claude ;

Pujade-Lauraine, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) :2718-2724

[9] Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial [J].

Badwe, Rajendra ;

Hawaldar, Rohini ;

Nair, Nita ;

Kaushik, Rucha ;

Parmar, Vani ;

Siddique, Shabina ;

Budrukkar, Ashwini ;

Mittra, Indraneel ;

Gupta, Sudeep .

LANCET ONCOLOGY, 2015, 16 (13) :1380-1388

[10] Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice? [J].

Berger, Ann M. ;

Mitchell, Sandra A. ;

Jacobsen, Paul B. ;

Pirl, William F. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (03) :190-211

← 1 2 3 4 5 6 7 →